{"database": "openregs", "table": "documents", "rows": [["FDA-2009-P-0471-0003", "FDA", "FDA-2009-P-0471", "Tab 3 - \"HCV Treatment With Pegylated Interferon and Ribavirin in Patients With Haemophilia and HIV/HCV Co-Infection\" - [Mark Antell, et al - Citizen Petition ] re FDA-2009-P-0471-0001", "Supporting & Related Material", "BKG-Background Material", "2009-10-05T04:00:00Z", 2009, 10, null, null, "2010-02-01T22:18:53Z", null, 0, 0, "0900006480a33573"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2009-P-0471-0003"], "units": {}, "query_ms": 1.0108421556651592, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}